TScan is dedicated to changing lives by discovering new cancer targets and developing safe and effective T-cell therapies for patients.
Within the tumors of cancer patients are T cells with the ability to recognize and eliminate cancer cells. We are using our proprietary target ID platform to identify the natural targets of tumor-reactive T cells and identify therapeutically active TCRs that are both safe and effective.
TScan’s experienced leadership team shares the goal of delivering groundbreaking cancer treatments to patients.
For more information about TScan, career or collaboration opportunities.
Chief Executive Officer
Chief Scientific Officer
Chief Business Officer
VP of Technical Development and Manufacturing
VP of Finance